Owlet (OWLT) 10-Q 13 May 22 2022 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2022	May 10, 2022
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2022
Document Transition Report	false
Entity File Number	001-39516
Entity Registrant Name	Owlet, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	85-1615012
Entity Address, Address Line One	3300 N. Ashton Blvd.
Entity Address, Address Line Two	Ste. 300
Entity Address, City or Town	Lehi
Entity Address, State or Province	UT
Entity Address, Postal Zip Code	84043
City Area Code	(844)
Local Phone Number	334-5330
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	true
Entity Small Business	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		113,478,021
Amendment Flag	false
Entity Central Index Key	0001816708
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31
Common Stock
Document Information [Line Items]
Title of 12(b) Security	Common stock, $0.0001 par value per share
Trading Symbol	OWLT
Security Exchange Name	NYSE
Warrants
Document Information [Line Items]
Title of 12(b) Security	Warrants to purchase common stock
Trading Symbol	OWLT WS
Security Exchange Name	NYSE

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 68,737	$ 95,054
Accounts receivable, net of allowance for doubtful accounts of $425 and $403, respectively	16,636	10,468
Inventory	24,713	17,980
Prepaid expenses and other current assets	6,652	12,313
Total current assets	116,738	135,815
Property and equipment, net	1,738	1,870
Right of use assets, net	2,727
Intangible assets, net	2,098	1,696
Other assets	815	666
Total assets	124,116	140,047
Current liabilities:
Accounts payable	23,521	27,765
Accrued and other expenses	35,156	31,730
Current portion of deferred revenues	1,128	1,061
Line of credit	4,644	0
Current portion of long-term debt	7,120	8,534
Total current liabilities	71,569	69,090
Long-term debt, net	6,493	7,993
Noncurrent lease liabilities	2,103
Common stock warrant liability	13,937	7,061
Other long-term liabilities	197	712
Total liabilities	94,299	84,856
Commitments and Contingencies
Stockholders’ equity:
Common stock, $0.0001 par value, 1,000,000,000 shares authorized as of March 31, 2022 and December 31, 2021; 113,406,474 and 112,996,568 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively.	11	11
Additional paid-in capital	201,986	198,602
Accumulated deficit	(172,180)	(143,422)
Total stockholders’ equity	29,817	55,191
Total liabilities and stockholders’ equity	$ 124,116	$ 140,047

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 425	$ 403
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	113,406,474	112,996,568
Common stock, shares outstanding (in shares)	113,406,474	112,996,568

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Revenues	$ 21,538	$ 21,911
Cost of revenues	12,782	9,228
Gross profit	8,756	12,683
Operating expenses:
General and administrative	10,276	5,981
Sales and marketing	11,631	6,118
Research and development	8,545	3,432
Total operating expenses	30,452	15,531
Operating loss	(21,696)	(2,848)
Other income (expense):
Interest expense, net	(226)	(417)
Preferred stock warrant liability adjustment	0	(4,608)
Common stock warrant liability adjustment	(6,876)	0
Other income (expense), net	47	21
Total other income (expense), net	(7,055)	(5,004)
Loss before income tax provision	(28,751)	(7,852)
Income tax provision	(7)	(5)
Net loss and comprehensive loss	$ (28,758)	$ (7,857)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.26)	$ (0.35)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.26)	$ (0.35)
Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic (in shares)	110,384,313	22,233,820
Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, diluted (in shares)	110,384,313	22,233,820

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholder's Equity (Deficit) - USD ($) $ in Thousands		Total	Preferred Stock Series A	Preferred Stock Series A-1	Preferred Stock Series B	Preferred Stock Series B-1	Common Stock		Additional Paid-in Capital	Accumulated Deficit
Increase (Decrease) in Temporary Equity [Roll Forward]
Beginning balance	[1]		$ 9,569	$ 14,083	$ 18,854	$ 4,682
Beginning balance (in shares) at Dec. 31, 2020	[1]		26,157,622	20,238,201	12,366,306	3,047,183
Ending balance (in shares) at Mar. 31, 2021	[1]		26,157,622	20,238,201	12,366,306	3,047,183
Ending balance at Mar. 31, 2021	[1]		$ 9,569	$ 14,083	$ 18,854	$ 4,682
Beginning balance (in shares) at Dec. 31, 2020	[1]						22,118,619
Beginning balance at Dec. 31, 2020		$ (68,009)					$ 2	[1]	$ 3,707	$ (71,718)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in Shares)	[1]						367,432
Issuance of common stock upon exercise of stock options		244							244
Share-based compensation		828							828
Net loss		(7,857)								(7,857)
Ending balance (in shares) at Mar. 31, 2021	[1]						22,486,051
Ending balance at Mar. 31, 2021		(74,794)					$ 2	[1]	4,779	(79,575)
Increase (Decrease) in Temporary Equity [Roll Forward]
Beginning balance	[1]		9,569	14,083	18,854	4,682
Beginning balance	[1]		$ 0	$ 0	$ 0	$ 0
Beginning balance (in shares) at Dec. 31, 2021	[1]		0	0	0	0
Ending balance (in shares) at Mar. 31, 2022	[1]		0	0	0	0
Ending balance at Mar. 31, 2022	[1]		$ 0	$ 0	$ 0	$ 0
Beginning balance (in shares) at Dec. 31, 2021	[1]						112,996,568
Beginning balance at Dec. 31, 2021		55,191					$ 11	[1]	198,602	(143,422)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in Shares)	[1]						88,808
Issuance of common stock upon exercise of stock options		48							48
Issuance of common stock for restricted stock units vesting (in shares)	[1]						321,098
Share-based compensation		3,336							3,336
Net loss		(28,758)								(28,758)
Ending balance (in shares) at Mar. 31, 2022	[1]						113,406,474
Ending balance at Mar. 31, 2022		$ 29,817					$ 11	[1]	$ 201,986	$ (172,180)
Increase (Decrease) in Temporary Equity [Roll Forward]
Beginning balance	[1]		$ 0	$ 0	$ 0	$ 0
[1]	The shares of the Company’s common and redeemable convertible preferred stock, prior to the merger with Sandbridge Acquisition Corporation on July 15, 2021 have been retrospectively adjusted as shares reflecting the exchange ratio of approximately 2.053 established in the Merger.

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholder's Equity (Deficit) (Parenthetical)	Mar. 31, 2022	Mar. 31, 2021
Redeemable Convertible Preferred Stock | Common Stock
Convertible preferred stock, conversion ratio	2.053	2.053

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net loss	$ (28,758)	$ (7,857)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization	348	249
Share-based compensation	3,318	828
Preferred stock warrant liability adjustment	0	4,608
Common stock warrant liability adjustment	6,876	0
Other adjustments, net	358	208
Changes in assets and liabilities:
Accounts receivable	(6,191)	(2,433)
Prepaid expenses and other assets	5,512	(2,912)
Inventory	(6,733)	(2,675)
Accounts payable and accrued and other expenses	(1,830)	3,022
Other, net	(296)	(14)
Net cash used in operating activities	(27,396)	(6,976)
Cash flows from investing activities
Purchase of property and equipment	(234)	(19)
Purchase of intangible assets	(466)	(8)
Net cash used in investing activities	(700)	(27)
Cash flows from financing activities
Proceeds from short-term borrowings	16,744	4,332
Payments of short-term borrowings	(13,514)	(1,771)
Payments of long-term borrowings	(1,500)	0
Other, net	49	244
Net cash provided by financing activities	1,779	2,805
Net change in cash and cash equivalents	(26,317)	(4,198)
Cash and cash equivalents at beginning of period	95,054	17,009
Cash and cash equivalents at end of period	$ 68,737	$ 12,811

Basis of Presentation

Basis of Presentation	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation Basis of Presentation and Principles of Consolidation The accompanying unaudited condensed consolidated financial statements of the Company and its subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and applicable rules and regulations of the U.S. Securities and Exchange Commission (the "SEC") regarding interim financial reporting. The condensed consolidated balance sheet as of December 31, 2021, included herein, was derived from the audited consolidated financial statements as of that date, but does not include all disclosures including certain notes required by U.S. GAAP on an annual reporting basis. All intercompany transactions and balances have been eliminated in consolidation. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary for the fair statement of the Company’s financial position, results of operations, and cash flows for the interim periods presented. All dollar amounts, except per share amounts, in the notes are presented in thousands, unless otherwise specified. As a result of the merger completed with Sandbridge Acquisition Corporation on July 15, 2021 (the "Merger"), prior period share and per share amounts presented in the accompanying consolidated financial statements and these related notes have been retrospectively adjusted. See Part II, Item 8 "Financial Statements and Supplementary Data - Note 3 to the Consolidated Financial Statements - Merger" in the 2021 Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the "Form 10-K") for more information. The Company adopted Accounting Standards Update ("ASU") No. 2016-02, Leases (Topic 842) on January 1, 2022 using the modified retrospective transition method. Prior periods were not retrospectively adjusted and continue to be reported under the accounting standards in effect for those periods, as further discussed in Note 3. Certain prior year amounts have been reclassified to conform to the current period presentation. Food and Drug Administration Letter On October 1, 2021, the Company received a Warning Letter, later corrected in an amendment to the letter dated October 5, 2021 (the “Warning Letter”), from the U.S. Food and Drug Administration (the “FDA”) regarding the Owlet Smart Sock. During the fourth quarter of 2021, the Company agreed with certain customers and retailers to accept returns of the Owlet Smart Sock and Owlet Monitor Duo. A refund liability of $18,210 and $20,145 has been accrued as of March 31, 2022 and December 31, 2021, respectively, in accrued and other expenses and represents the amount due to customers. As of March 31, 2022, the Company has recorded $6,172 within inventory for returned inventory received and a $2,047 asset within prepaid expenses and other current assets for inventory expected to be returned but not yet received. Risks and Uncertainties Since inception, the Company has experienced recurring losses from operations and generated negative cash flows from operations. The Company has an accumulated deficit as of March 31, 2022 of $172,180 and expects to incur additional losses from operations in the future. On July 15, 2021, the Company completed the Merger and received $133,889 in combined net proceeds from the Merger and the private investment in the Company's equity (the "PIPE"). Therefore, as of the date on which these consolidated financial statements were issued, the Company believes that its cash on hand, together with cash generated from sales to customers, will satisfy its working capital and capital requirements for at least the next twelve months. However, we are still in the growth stage of our business and expect to continue to make substantial investments in our business, including in the expansion of our product portfolio and in our research and development, sales and marketing teams, in addition to incurring additional costs as a result of being a public company. There can be no assurance that we will be able to obtain additional debt or equity financing on terms acceptable to us, if at all, or that we will generate sufficient future revenues. The Company maintains its cash in bank deposit accounts which, at times, exceed federally insured limits. As of March 31, 2022, all of the Company's cash was held with Silicon Valley Bank and exceeded federally insured limits. To date, the Company has not experienced a loss or lack of access to its invested cash; however, no assurance can be provided that access to the Company’s invested cash and cash equivalents will not be impacted by adverse conditions in the financial markets.

Certain Balance Sheet Accounts

Certain Balance Sheet Accounts	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Certain Balance Sheet Accounts	Certain Balance Sheet Accounts Inventory Substantially all of the Company's inventory consisted of finished goods as of March 31, 2022 and December 31, 2021. Property and Equipment, net Property and equipment consisted of the following as of: March 31, 2022 December 31, 2021 Tooling and manufacturing equipment $ 2,481 $ 2,333 Furniture and fixtures 579 579 Computer equipment 654 625 Software 213 213 Leasehold improvements 26 26 Total property and equipment 3,953 3,776 Less accumulated depreciation and amortization (2,215) (1,906) Property and equipment, net $ 1,738 $ 1,870 Depreciation and amortization expense on property and equipment was $309 and $214 for the three months ended March 31, 2022 and March 31, 2021, respectively. For the three months ended March 31, 2022 and March 31, 2021, the Company allocated $190 and $150, respectively, of depreciation and amortization expense related to tooling and manufacturing equipment and software to cost of revenues. Intangible Assets Subject to Amortization Intangible assets were $2,098, net of accumulated amortization of $368 as of March 31, 2022 and $1,696, net of accumulated amortization of $329, as of December 31, 2021. Capitalized software development costs were $1,541 and $1,101 as of March 31, 2022 and December 31, 2021, respectively. The Company's internally developed software capitalized within intangible assets on the balance sheet is still in development and not ready for general release. As such, the Company has not recognized any amortization for the three months ended March 31, 2022. The Company did not recognize any impairment charges for intangible assets during the three months ended March 31, 2022 or 2021. Accrued and Other Expenses Accrued and other expenses, among other things, included accrued sales returns of $20,668 and $21,179 as of March 31, 2022 and December 31, 2021, respectively. As described in Note 1, $18,210 and $20,145 of the accrued sales returns as of March 31, 2022 and December 31, 2021, respectively, was attributable to returns resulting from the Warning Letter. Changes in accrued warranty were as follows: For the Three Months Ended March 31, 2022 2021 Accrued warranty, beginning of period $ 661 $ 924 Provision for warranties issued during the period 200 242 Settlements of warranty claims during the period (136) (244) Accrued warranty, end of period $ 725 $ 922 Stockholders' Equity The Company is authorized to issue up to 100,000,000 shares of $0.0001 par value preferred stock, of which none is currently outstanding.

Leases

Leases	3 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Leases	Leases The new lease standard was adopted on January 1, 2022 using the modified retrospective transition method. Prior periods were not retrospectively adjusted and continue to be reported under the accounting standards in effect for those periods. The Company elected the package of practical expedients permitted under the transition guidance and did not reassess prior conclusions related to contracts containing leases, lease classification and initial direct costs. The Company also elected the practical expedients to exclude right-of-use ("ROU") assets and lease liabilities for leases with an initial term of 12 months or less from the balance sheet, and to combine lease and non-lease components for property leases, which primarily relate to ancillary expenses such as common area maintenance charges and management fees. Leases are determined at inception by assessing whether the arrangement conveys the right to control the use of an identified asset for a period of time in exchange for consideration. Owlet's leases consist of leases for corporate offices and office equipment, and have remaining lease terms of 2 to 5 years, with options for renewal. Renewal and termination options have not been included in the lease terms, as it is not reasonably certain that such options will be exercised. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. Leases typically contain rent escalations over the lease term. The Company recognizes expense for these leases on a straight-line basis over the lease term. Certain leases require the Company to pay taxes, insurance, maintenance and other operating expenses associated with the leased asset. Such amounts are not included in the measurement of the ROU assets and lease liabilities to the extent they are variable in nature. These variable lease costs are recognized as a variable lease expense when incurred. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Owlet uses its incremental borrowing rate, based on the information available at the lease commencement date, to determine the present value of lease payments. Upon adoption, Owlet recorded lease assets and lease liabilities of approximately $3,003 and $3,764, respectively, which did not have a net impact on the condensed consolidated statement of cash flows for the three months ended March 31, 2022. The lease assets were adjusted for deferred rent, lease incentives, and prepaid rent, which were recorded as a decrease to accrued and other expenses and other long-term liabilities for the amounts of $234 and $527, respectively. There were no finance leases as of adoption or during the quarter. Income from subleased properties is recognized on a straight-line basis and presented as a reduction of costs, allocated among operating expense line items in the Company’s Consolidated Statements of Operations and Comprehensive Loss. In addition to sublease rent, variable non-lease costs such as common area maintenance and utilities are charged to subtenants over the duration of the lease for their proportionate share of these costs. These variable non-lease income receipts are recognized in operating expenses as a reduction to costs incurred by the Company in relation to the head lease. The impact of the new lease standard on the March 31, 2022 consolidated balance sheet was as follows: March 31, 2022 Right of use assets, net $ 2,727 Accrued and other expenses $ 1,336 Noncurrent lease liabilities 2,103 Total lease liabilities, net $ 3,439 Weighted average remaining lease term 2.3 years Weighted average discount rate 6.5% Operating lease costs are recognized on a straight-line basis over the lease term. Total operating lease costs for the three months ended March 31, 2022 were $346, which included approximately $11 related to short-term and variable lease costs. Supplemental cash flow information related to leases was as follows: March 31, 2022 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows $ 385 The following table shows the future maturities of lease liabilities for leases in effect as of March 31, 2022: Years Ending December 31, Lease Liabilities 2022 (excluding the three months ended March 31, 2022) $ 1,156 2023 1,587 2024 953 Total lease payments 3,696 Less: imputed interest (257) Total $ 3,439 As of March 31, 2022, the Company had four sublease arrangements which are noncancellable and have remaining lease terms of 0.5 to 2.5 years. These subleases do not contain any options to renew or terminate the sublease agreement. The following table shows the expected future sublease receipts as of March 31, 2022: Years Ending December 31, Sublease Receipts 2022 (excluding the three months ended March 31, 2022) $ 947 2023 1,178 2024 679 Total expected sublease receipts $ 2,804 The Company received sublease income of $113 and $17 for the three months ended March 31, 2022 and March 31, 2021, respectively. As previously disclosed in our 2021 Annual Report on Form 10-K and under the previous lease standard (Topic ASC 840), future minimum lease payments under non-cancelable operating leases at December 31, 2021 were as follows: Years Ending December 31, Amount 2022 $ 1,541 2023 1,587 2024 953 Total $ 4,081 Rental expense under operating leases was approximately $371 for the three months ended March 31, 2021.
Leases	Leases The new lease standard was adopted on January 1, 2022 using the modified retrospective transition method. Prior periods were not retrospectively adjusted and continue to be reported under the accounting standards in effect for those periods. The Company elected the package of practical expedients permitted under the transition guidance and did not reassess prior conclusions related to contracts containing leases, lease classification and initial direct costs. The Company also elected the practical expedients to exclude right-of-use ("ROU") assets and lease liabilities for leases with an initial term of 12 months or less from the balance sheet, and to combine lease and non-lease components for property leases, which primarily relate to ancillary expenses such as common area maintenance charges and management fees. Leases are determined at inception by assessing whether the arrangement conveys the right to control the use of an identified asset for a period of time in exchange for consideration. Owlet's leases consist of leases for corporate offices and office equipment, and have remaining lease terms of 2 to 5 years, with options for renewal. Renewal and termination options have not been included in the lease terms, as it is not reasonably certain that such options will be exercised. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. Leases typically contain rent escalations over the lease term. The Company recognizes expense for these leases on a straight-line basis over the lease term. Certain leases require the Company to pay taxes, insurance, maintenance and other operating expenses associated with the leased asset. Such amounts are not included in the measurement of the ROU assets and lease liabilities to the extent they are variable in nature. These variable lease costs are recognized as a variable lease expense when incurred. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Owlet uses its incremental borrowing rate, based on the information available at the lease commencement date, to determine the present value of lease payments. Upon adoption, Owlet recorded lease assets and lease liabilities of approximately $3,003 and $3,764, respectively, which did not have a net impact on the condensed consolidated statement of cash flows for the three months ended March 31, 2022. The lease assets were adjusted for deferred rent, lease incentives, and prepaid rent, which were recorded as a decrease to accrued and other expenses and other long-term liabilities for the amounts of $234 and $527, respectively. There were no finance leases as of adoption or during the quarter. Income from subleased properties is recognized on a straight-line basis and presented as a reduction of costs, allocated among operating expense line items in the Company’s Consolidated Statements of Operations and Comprehensive Loss. In addition to sublease rent, variable non-lease costs such as common area maintenance and utilities are charged to subtenants over the duration of the lease for their proportionate share of these costs. These variable non-lease income receipts are recognized in operating expenses as a reduction to costs incurred by the Company in relation to the head lease. The impact of the new lease standard on the March 31, 2022 consolidated balance sheet was as follows: March 31, 2022 Right of use assets, net $ 2,727 Accrued and other expenses $ 1,336 Noncurrent lease liabilities 2,103 Total lease liabilities, net $ 3,439 Weighted average remaining lease term 2.3 years Weighted average discount rate 6.5% Operating lease costs are recognized on a straight-line basis over the lease term. Total operating lease costs for the three months ended March 31, 2022 were $346, which included approximately $11 related to short-term and variable lease costs. Supplemental cash flow information related to leases was as follows: March 31, 2022 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows $ 385 The following table shows the future maturities of lease liabilities for leases in effect as of March 31, 2022: Years Ending December 31, Lease Liabilities 2022 (excluding the three months ended March 31, 2022) $ 1,156 2023 1,587 2024 953 Total lease payments 3,696 Less: imputed interest (257) Total $ 3,439 As of March 31, 2022, the Company had four sublease arrangements which are noncancellable and have remaining lease terms of 0.5 to 2.5 years. These subleases do not contain any options to renew or terminate the sublease agreement. The following table shows the expected future sublease receipts as of March 31, 2022: Years Ending December 31, Sublease Receipts 2022 (excluding the three months ended March 31, 2022) $ 947 2023 1,178 2024 679 Total expected sublease receipts $ 2,804 The Company received sublease income of $113 and $17 for the three months ended March 31, 2022 and March 31, 2021, respectively. As previously disclosed in our 2021 Annual Report on Form 10-K and under the previous lease standard (Topic ASC 840), future minimum lease payments under non-cancelable operating leases at December 31, 2021 were as follows: Years Ending December 31, Amount 2022 $ 1,541 2023 1,587 2024 953 Total $ 4,081 Rental expense under operating leases was approximately $371 for the three months ended March 31, 2021.

Deferred Revenues

Deferred Revenues	3 Months Ended
	Mar. 31, 2022
Deferred Revenue [Abstract]
Deferred Revenues	Deferred RevenuesDeferred revenues relate to performance obligations for which payments are received from customers prior to the satisfaction of the Company’s obligations to its customers. Deferred revenues primarily consist of amounts allocated to the mobile application, unspecified upgrade rights, and content, and are recognized over the service period of the performance obligations, which range from 5 to 27 months. Changes in the total deferred revenues balance were as follows: For the Three Months Ended March 31, 2022 2021 Beginning balance $ 1,235 $ 1,802 Deferral of revenues 744 818 Recognition of deferred revenues (667) (895) Ending balance $ 1,312 $ 1,725 The Company recognized $550 and $732 of revenue during the three months ended March 31, 2022 and 2021, respectively, that was included in the deferred revenue balance at the beginning of the respective period.

Long-Term Debt and Other Financ

Long-Term Debt and Other Financing Arrangements	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Long-Term Debt and Other Financing Arrangements	Long-Term Debt and Other Financing Arrangements The following is a summary of the Company’s long-term indebtedness as of: March 31, 2022 December 31, 2021 Term note payable to SVB, maturing on April 1, 2024 $ 12,500 $ 14,000 Financed insurance premium 1,120 2,534 Total debt 13,620 16,534 Less: current portion (7,120) (8,534) Less: debt discount and debt issuance costs (7) (7) Total long-term debt, net $ 6,493 $ 7,993 Term Note The Company has an amended and restated loan and security agreement (the "A&R LSA") with Silicon Valley Bank (‘‘SVB’’) which was entered into on April 22, 2020, and which replaced the loan and security agreement previously in place (the ‘‘Original LSA’’). These agreements provided the Company with both a line of credit (the ‘‘SVB Revolver’’) and a term loan (the ‘‘Term Note’’). On January 31, 2022, the Company further amended the A&R LSA, which modified the SVB Revolver annual interest rate, decreased the advance rate for borrowing base assets, and increased the cash and cash availability streamline threshold. The amendment also modified the Term Note annual interest rates, replaced the existing EBITDA covenant for 2022 and beyond with a net revenue covenant, and increased the minimum cash and cash availability threshold from $5,000 to $30,000. As of March 31, 2022, the Term Note had an aggregate principal balance of $12,500 as of March 31, 2022, bore interest at a rate equal to the greater of the bank's prime rate plus 2.50%, or 5.75%, and required 30 consecutive equal monthly payments of principal and matures on April 1, 2024. Prior to January 31, 2022, the Term Note bore interest at a rate equal to the greater of the bank's prime rate plus 3.50%, or 6.50%. The Company's borrowings under the A&R LSA are secured by substantially all of its current and future assets. Future Aggregate Maturities As of March 31, 2022, future aggregate maturities of the Term Note and Financed Insurance Premium payables were as follows: Years Ending December 31, Amount 2022 (excluding the three months ended March 31, 2022) $ 5,620 2023 6,000 2024 2,000 Total $ 13,620 Financed Insurance Premium During the year ended December 31, 2021, the Company renewed its corporate liability policies and entered into several new short-term commercial premium finance agreements with AFCO Credit Corporation totaling $4,699 to be paid in ten equal monthly payments, all of which accrue interest at a rate of 3.59%. As of March 31, 2022, the remaining principal balance on the financed insurance premium was $1,120. Line of Credit As of March 31, 2022, our borrowing capacity under the SVB Revolver was $17,500 and bore interest at an annual rate equal to (i) the greater of the bank’s prime rate plus 0.75%, or 5.00% when a streamline period is in effect and (ii) the greater of the bank’s prime rate plus 1.25%, or 5.00% at all other times. The SVB Revolver is an asset based lending facility subject to borrowing base availability which is limited by specified percentages of eligible accounts receivable and eligible inventory. Borrowing base availability can be impacted based upon the period's eligible accounts receivable and eligible inventory, and may be significantly lower than borrowing base capacity. Prior to January 31, 2022, the SVB Revolver bore interest at an annual rate equal to (i) the greater of the bank’s prime rate plus 0.75%, or 5.50% when a streamline period is in effect and (ii) the greater of the bank’s prime rate plus 1.25%, or 6.00% at all other times. Each streamline period commences the first day of the month following a written report of our liquidity and ends the first day after we fail to maintain a required cash and cash availability streamline threshold, provided no event of default has occurred and is continuing. If an event of default has occurred and is continuing, SVB may maintain our streamline status at its discretion. The required cash and cash availability streamline threshold was $50,000 as of March 31, 2022, and we were within a streamline period. The actual interest rate on the SVB Revolver was 5.50% as of March 31, 2022. The SVB Revolver is subject to renewal and is scheduled to mature on April 22, 2024. As of March 31, 2022, there was $4,644 of outstanding borrowings under the SVB Revolver. As of March 31, 2022, the Company was in compliance with all applicable covenants.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Litigation The Company is involved in legal proceedings from time to time arising in the normal course of business. Management, after consultation with legal counsel, believes that the outcome of these proceedings will not have a material impact on the Company’s financial position, results of operations, or liquidity. In November 2021, two putative class action complaints were filed against us in the U.S. District Court for the Central District of California, the first captioned Butala v. Owlet, Inc., et al., Case No. 2:21-cv-09016, and the second captioned Cherian v. Owlet, Inc., et al., Case No. 2:21-cv-09293. Both complaints allege violations of the Securities Exchange Act of 1934 against the Company and certain of its officers and directors on behalf of a putative class of investors who: (a) purchased the Company’s common stock between March 31, 2021 and October 4, 2021; or (b) held common stock in SBG as of June 1, 2021, and were eligible to vote in the Special Meeting held on July 14, 2021. Both complaints allege, among other things, that the Company and certain of its officers and directors made false and/or misleading statements and failed to disclose certain information regarding the FDA’s likely classification of the Owlet Smart Sock as a medical device requiring marketing authorization. The Court has pending before it motions to consolidate the Butala and Cherian cases and appoint a lead plaintiff. The Company intends to vigorously defend itself against these claims, including by filing a motion to dismiss on behalf of itself and the named officers and directors. A reasonable estimate of the amount of any possible loss or range of loss cannot be made at this time. Indemnification In the ordinary course of business, the Company enters into agreements that may include indemnification provisions. Pursuant to such agreements, the Company may indemnify, hold harmless, and defend an indemnified party for losses suffered or incurred by the indemnified party. Some of the provisions will limit losses to those arising from third party actions. In some cases, the indemnification will continue after the termination of the agreement. The maximum potential amount of future payments the Company could be required to make under these provisions is not determinable. The Company has never incurred material costs to defend lawsuits or settle claims related to these indemnification provisions. The Company has entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against liabilities that may arise by reason of their status or service as directors or officers to the fullest extent permitted by Delaware corporate law. The Company currently has directors’ and officers’ insurance coverage that reduces its exposure and enables the Company to recover a portion of any future amounts paid. The Company believes the estimated fair value of these indemnification agreements in excess of applicable insurance coverage is immaterial.

Share-based Compensation

Share-based Compensation	3 Months Ended
	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
Share-based Compensation	Share-based Compensation The company has various stock compensation plans, which are more fully described in Part II, Item 8 "Financial Statements and Supplementary Data - Note 9 to the Consolidated Financial Statements - Share-based Compensation" in the 2021 Annual Report on Form 10-K. Under the 2021 Incentive Award Plan, the Company has the ability to grant options, stock appreciation rights, restricted stock, restricted stock units, performance stock units, dividend equivalents, or other stock or cash-based awards to employees, directors, or consultants. During the three months ended March 31, 2022, the Company granted 1,842,105 performance restricted stock units ("PRSU"), which represents the number of shares that may be issued should all performance measures be met. The PRSU awards function in the same manner as restricted stock units except that vesting terms are based on achievement of performance measures, such as the achievement of net revenue targets and obtaining certain FDA regulatory approval. PRSUs are recognized as expense following a graded vesting schedule with their performance re-assessed and updated on a quarterly basis, or more frequently as changes in facts and circumstances warrant. On January 1, 2022, the Company began offering an Employee Stock Purchase Plan ("ESPP"). The ESPP allows eligible employees to contribute a portion of their eligible earnings toward the semi-annual purchase of our shares of common stock at a discounted price, subject to an annual maximum dollar amount. Employees can purchase stock at a 15% discount applied to the lower closing stock price on the first or last day of the six Option awards are generally granted with an exercise price equal to the fair value of the Company’s common stock at the date of grant. Options, RSU, and PRSU awards generally vest over a period of four years. Stock-based Compensation Expense Total stock-based compensation was recognized as follows (in thousands): Three Months Ended March 31, 2022 2021 General and administrative $ 1,544 $ 398 Sales and marketing 740 194 Research and development 1,034 236 Total stock-based compensation $ 3,318 $ 828 During the three months ended March 31, 2022, the Company capitalized $18 of share-based compensation attributable to internally developed software.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The following table presents information about the Company's assets and liabilities measured and reported in the financial statements at fair value on a recurring basis and indicates the fair value hierarchy of the valuation techniques utilized to determine such fair value. March 31, 2022 Level 1 Level 2 Level 3 Balance Assets: Money market funds $ 68,726 $ — $ — $ 68,726 Total assets $ 68,726 $ — $ — $ 68,726 Liabilities: Common Stock warrant liability - Public Warrants $ 8,855 $ — $ — $ 8,855 Common Stock warrant liability - Private Placement Warrants — 5,082 — 5,082 Total liabilities $ 8,855 $ 5,082 $ — $ 13,937 December 31, 2021 Level 1 Level 2 Level 3 Balance Assets: Money market funds $ 94,973 $ — $ — $ 94,973 Total assets $ 94,973 $ — $ — $ 94,973 Liabilities: Common Stock warrant liability - Public Warrants $ 4,486 $ — $ 4,486 Common Stock warrant liability - Private Placement Warrants $ 2,575 $ 2,575 Total liabilities $ 4,486 $ 2,575 $ — $ 7,061 Money market funds are included within Level 1 of the fair value hierarchy because they are valued using quoted market prices. The common stock warrant liability for the Public Warrants as of March 31, 2022 is also included within Level 1 of the fair value hierarchy because they are valued using quoted market prices. The Private Placement Warrants are included within Level 2 of the fair value hierarchy as the Company determined that the Private Placement Warrants are economically equivalent to the Public Warrants and estimated the fair value of the Private Placement Warrants based on the quoted market price of the Public Warrants. The Company has previously presented the fair value measurement of the preferred stock warrant liability as a Level 3 measurement, relying on unobservable inputs reflecting the Company’s own assumptions. Level 3 measurements, which are not based on quoted prices in active markets, introduce a higher degree of subjectivity and may be more sensitive to fluctuations in stock price, volatility rates, and U.S. Treasury Bond rates. The preferred stock warrants were settled immediately prior to the Merger. The Company re-measured the preferred stock warrant liability to its estimated fair value as of March 31, 2021, using the Black-Scholes option pricing model with the following assumptions: March 31, 2021 Series A preferred stock value per share $ 18.23 Exercise price of warrants $ 0.76 Term in years 5.5 Risk-free interest rate 1.04 % Volatility 67.00 % Dividend yield 0.00 % The following table presents a reconciliation of the Company’s preferred stock warrant liability measured at fair value on a recurring basis using significant unobservable inputs (Level 3) as of March 31, 2021: Preferred Stock Warrant Liability Balance as of December 31, 2020 $ 2,993 Change in fair value included in other income 4,608 Balance as of March 31, 2021 $ 7,601 There were no transfers between Level 1 and Level 2 in the periods reported. There were no transfers into or out of Level 3 in the period reported.

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes In order to determine the quarterly provision for income taxes, the Company uses an estimated annual effective tax rate, which is based on expected annual income and statutory tax rates in the various jurisdictions in which the Company operates. To the extent that application of the estimated annual effective tax rate is not representative of the quarterly portion of actual tax expense expected to be recorded for the year, the Company determines the quarterly provision for income taxes based on actual year-to-date income. Certain significant or unusual items are separately recognized in the quarter during which they occur and can be a source of variability in the effective tax rates from quarter to quarter. The provision for income taxes was $7 and $5, for the three months ended March 31, 2022 and March 31, 2021, respectively. Significant judgment is required in determining the Company’s provision for income taxes, recording valuation allowances against deferred tax assets, and evaluating the Company’s uncertain tax positions. In evaluating the ability to realize its deferred tax assets, in full or in part, the Company considers all available positive and negative evidence, including past operating results, forecasted future earnings, and prudent and feasible tax planning strategies. Due to historical net losses incurred and the uncertainty of realizing the deferred tax assets, for all the periods presented, the Company maintains a valuation allowance against the net U.S. deferred tax assets. The Company files U.S. and state income tax returns in jurisdictions with various statutes of limitations. The Company’s federal and state tax returns are not currently under examination.

Net Loss Per Share Attributable

Net Loss Per Share Attributable to Common Stockholders	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Net Loss Per Share Attributable to Common Stockholders	Net Loss Per Share Attributable to Common Stockholders The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share amounts): Three Months Ended March 31, 2022 2021 Numerator: Net loss attributable to common stockholders (1) $ (28,758) $ (7,857) Denominator: Weighted-average common shares used in computed net loss per share attributable to common stockholders basic and diluted 110,384,313 22,233,820 Net loss per share attributable to common stockholders basic and diluted $ (0.26) $ (0.35) (1) For the three months ended March 31, 2021, the Company did not allocate its net loss to participating redeemable convertible preferred stock as those shares are not obligated to share in the losses of the Company. As of March 31, 2022, the Company no longer has participating redeemable convertible preferred stock. The following potentially dilutive outstanding securities were excluded from the computation of diluted net loss per share due to their anti-dilutive effect: As of March 31, 2022 Stock options 9,866,965 RSUs 6,557,326 PRSUs 1,842,105 ESPP shares committed 234,133 Common stock warrants 18,100,000 Total 36,600,529 The Company’s 2,807,500 unvested earnout shares were excluded from the calculation of basic and diluted per share calculations as the vesting conditions have not yet been met as of March 31, 2022. As of March 31, 2021 Stock options 11,186,265 Common stock warrants 942,623 Convertible notes 4,573,466 Preferred stock 61,809,312 Preferred stock warrants 889,765 Total (1) 79,401,431 (1) Securities shown as of March 31, 2021 have been retrospectively adjusted reflecting the exchange ratio of approximately 2.053 established in the Merger. See Part II, Item 8 "Financial Statements and Supplementary Data - Note 3 to the Consolidated Financial Statements - Merger" in the 2021 Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the "Form 10-K") for more information.

Segments

Segments	3 Months Ended
	Mar. 31, 2022
Segment Reporting [Abstract]
Segments	SegmentsThe Company operates as a single operating segment. The Company’s chief operating decision maker manages the Company's operations on a consolidated basis for purposes of allocating resources, making operating decisions, and evaluating financial performance. Since the Company operates in one operating segment, all required financial segment information can be found in these consolidated financial statements. Revenue by geographic area is based on the delivery address of the customer and is summarized as follows (in thousands): Three Months Ended March 31, 2022 2021 United States $ 18,712 $ 20,534 International 2,826 1,377 Total revenues $ 21,538 $ 21,911 Other than the United States, no individual country exceeded 10% of total revenues for either of the three months ended March 31, 2022 and March 31, 2021. The Company’s property and equipment, net, by geographic area are summarized as follows as of (in thousands): March 31, 2022 December 31, 2021 United States $ 610 $ 705 International 1,128 1,165 Total property and equipment, net $ 1,738 $ 1,870

New Accounting Pronouncements

New Accounting Pronouncements	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
New Accounting Pronouncements	New Accounting Pronouncements Recently Adopted Accounting Pronouncements In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), related to leases to increase transparency and comparability among organizations by requiring the recognition of right-of-use (“ROU”) assets obtained in exchange for lease liabilities on the balance sheet. Most prominent among the changes in the standard is the recognition of ROU assets and lease liabilities by lessees for those leases classified as operating leases. Under the standard, disclosures are required to meet the objective of enabling users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. The Company adopted the new guidance as of January 1, 2022. See Note 3 for the impact of adoption on these condensed consolidated financial statements. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as the elimination of exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period, the recognition of deferred tax liabilities for outside basis differences, ownership changes in investments, and tax basis step-up in goodwill obtained in a transaction that is not a business combination. The guidance will be effective for annual reporting periods beginning after December 15, 2021. The Company adopted ASU 2019-12 in the first quarter of 2022. The adoption of this standard does not currently have a material impact on the Company's consolidated financial statements. In August 2020, the FASB issued ASU 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging Contracts in Entity’s Own Equity (Subtopic 815-40), which simplifies the accounting for convertible instruments by removing major separation models required under current guidance. ASU 2020-06 also removes certain settlement conditions that are required for equity contracts to qualify for derivative scope exception and simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for annual reporting periods beginning after December 15, 2021, including interim periods. The Company adopted ASU 2020-06 on January 1, 2022. The adoption of this standard does not currently have a material impact on the Company's consolidated financial statements. Recently Issued Accounting Standards Not Yet Adopted In June 2016, the FASB issued ASU 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, and has since released various amendments including ASU No. 2019-04. The guidance modifies the measurement of expected credit losses on certain financial instruments. This guidance will be effective for annual reporting periods beginning after December 15, 2022. Early adoption is permitted. The Company is currently assessing the impact of the guidance on its consolidated financial statements and disclosures.

Basis of Presentation (Policies

Basis of Presentation (Policies)	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The accompanying unaudited condensed consolidated financial statements of the Company and its subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and applicable rules and regulations of the U.S. Securities and Exchange Commission (the "SEC") regarding interim financial reporting. The condensed consolidated balance sheet as of December 31, 2021, included herein, was derived from the audited consolidated financial statements as of that date, but does not include all disclosures including certain notes required by U.S. GAAP on an annual reporting basis. All intercompany transactions and balances have been eliminated in consolidation. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary for the fair statement of the Company’s financial position, results of operations, and cash flows for the interim periods presented. All dollar amounts, except per share amounts, in the notes are presented in thousands, unless otherwise specified. As a result of the merger completed with Sandbridge Acquisition Corporation on July 15, 2021 (the "Merger"), prior period share and per share amounts presented in the accompanying consolidated financial statements and these related notes have been retrospectively adjusted. See Part II, Item 8 "Financial Statements and Supplementary Data - Note 3 to the Consolidated Financial Statements - Merger" in the 2021 Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the "Form 10-K") for more information. The Company adopted Accounting Standards Update ("ASU") No. 2016-02, Leases (Topic 842) on January 1, 2022 using the modified retrospective transition method. Prior periods were not retrospectively adjusted and continue to be reported under the accounting standards in effect for those periods, as further discussed in Note 3. Certain prior year amounts have been reclassified to conform to the current period presentation.

New Accounting Pronouncements (

New Accounting Pronouncements (Policies)	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Recently Adopted Accounting Pronouncements and Recently Issued Accounting Standards Not Yet Adopted	Recently Adopted Accounting Pronouncements In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), related to leases to increase transparency and comparability among organizations by requiring the recognition of right-of-use (“ROU”) assets obtained in exchange for lease liabilities on the balance sheet. Most prominent among the changes in the standard is the recognition of ROU assets and lease liabilities by lessees for those leases classified as operating leases. Under the standard, disclosures are required to meet the objective of enabling users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. The Company adopted the new guidance as of January 1, 2022. See Note 3 for the impact of adoption on these condensed consolidated financial statements. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as the elimination of exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period, the recognition of deferred tax liabilities for outside basis differences, ownership changes in investments, and tax basis step-up in goodwill obtained in a transaction that is not a business combination. The guidance will be effective for annual reporting periods beginning after December 15, 2021. The Company adopted ASU 2019-12 in the first quarter of 2022. The adoption of this standard does not currently have a material impact on the Company's consolidated financial statements. In August 2020, the FASB issued ASU 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging Contracts in Entity’s Own Equity (Subtopic 815-40), which simplifies the accounting for convertible instruments by removing major separation models required under current guidance. ASU 2020-06 also removes certain settlement conditions that are required for equity contracts to qualify for derivative scope exception and simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for annual reporting periods beginning after December 15, 2021, including interim periods. The Company adopted ASU 2020-06 on January 1, 2022. The adoption of this standard does not currently have a material impact on the Company's consolidated financial statements. Recently Issued Accounting Standards Not Yet Adopted In June 2016, the FASB issued ASU 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, and has since released various amendments including ASU No. 2019-04. The guidance modifies the measurement of expected credit losses on certain financial instruments. This guidance will be effective for annual reporting periods beginning after December 15, 2022. Early adoption is permitted. The Company is currently assessing the impact of the guidance on its consolidated financial statements and disclosures.

Certain Balance Sheet Accounts

Certain Balance Sheet Accounts (Tables)	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Property and Equipment	Property and equipment consisted of the following as of: March 31, 2022 December 31, 2021 Tooling and manufacturing equipment $ 2,481 $ 2,333 Furniture and fixtures 579 579 Computer equipment 654 625 Software 213 213 Leasehold improvements 26 26 Total property and equipment 3,953 3,776 Less accumulated depreciation and amortization (2,215) (1,906) Property and equipment, net $ 1,738 $ 1,870
Schedule of Accrued Warranty	Changes in accrued warranty were as follows: For the Three Months Ended March 31, 2022 2021 Accrued warranty, beginning of period $ 661 $ 924 Provision for warranties issued during the period 200 242 Settlements of warranty claims during the period (136) (244) Accrued warranty, end of period $ 725 $ 922

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Impact of New Lease Standard on Balance Sheet	The impact of the new lease standard on the March 31, 2022 consolidated balance sheet was as follows: March 31, 2022 Right of use assets, net $ 2,727 Accrued and other expenses $ 1,336 Noncurrent lease liabilities 2,103 Total lease liabilities, net $ 3,439 Weighted average remaining lease term 2.3 years Weighted average discount rate 6.5%
Supplemental Cash Flow Information Related to Leases	Supplemental cash flow information related to leases was as follows: March 31, 2022 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows $ 385
Schedule of Future Maturities of Lease Liabilities	The following table shows the future maturities of lease liabilities for leases in effect as of March 31, 2022: Years Ending December 31, Lease Liabilities 2022 (excluding the three months ended March 31, 2022) $ 1,156 2023 1,587 2024 953 Total lease payments 3,696 Less: imputed interest (257) Total $ 3,439
Schedule of Expected Future Sublease Receipts	The following table shows the expected future sublease receipts as of March 31, 2022: Years Ending December 31, Sublease Receipts 2022 (excluding the three months ended March 31, 2022) $ 947 2023 1,178 2024 679 Total expected sublease receipts $ 2,804
Schedule of Future Maturities of Lease Liabilities, Topic 840	As previously disclosed in our 2021 Annual Report on Form 10-K and under the previous lease standard (Topic ASC 840), future minimum lease payments under non-cancelable operating leases at December 31, 2021 were as follows: Years Ending December 31, Amount 2022 $ 1,541 2023 1,587 2024 953 Total $ 4,081

Deferred Revenues (Tables)

Deferred Revenues (Tables)	3 Months Ended
	Mar. 31, 2022
Deferred Revenue [Abstract]
Summary of Changes in the total deferred revenues balance	Changes in the total deferred revenues balance were as follows: For the Three Months Ended March 31, 2022 2021 Beginning balance $ 1,235 $ 1,802 Deferral of revenues 744 818 Recognition of deferred revenues (667) (895) Ending balance $ 1,312 $ 1,725

Long-Term Debt and Other Fina_2

Long-Term Debt and Other Financing Arrangements (Tables)	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Summary of the Company's Long-term Indebtedness	The following is a summary of the Company’s long-term indebtedness as of: March 31, 2022 December 31, 2021 Term note payable to SVB, maturing on April 1, 2024 $ 12,500 $ 14,000 Financed insurance premium 1,120 2,534 Total debt 13,620 16,534 Less: current portion (7,120) (8,534) Less: debt discount and debt issuance costs (7) (7) Total long-term debt, net $ 6,493 $ 7,993
Summary of Future Aggregate Maturities of Notes Payable	As of March 31, 2022, future aggregate maturities of the Term Note and Financed Insurance Premium payables were as follows: Years Ending December 31, Amount 2022 (excluding the three months ended March 31, 2022) $ 5,620 2023 6,000 2024 2,000 Total $ 13,620

Share-based Compensation (Table

Share-based Compensation (Tables)	3 Months Ended
	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
Schedule of Stock-based Compensation Expense	Total stock-based compensation was recognized as follows (in thousands): Three Months Ended March 31, 2022 2021 General and administrative $ 1,544 $ 398 Sales and marketing 740 194 Research and development 1,034 236 Total stock-based compensation $ 3,318 $ 828

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Summary of Assets and Liabilities Fair Value Measurement	The following table presents information about the Company's assets and liabilities measured and reported in the financial statements at fair value on a recurring basis and indicates the fair value hierarchy of the valuation techniques utilized to determine such fair value. March 31, 2022 Level 1 Level 2 Level 3 Balance Assets: Money market funds $ 68,726 $ — $ — $ 68,726 Total assets $ 68,726 $ — $ — $ 68,726 Liabilities: Common Stock warrant liability - Public Warrants $ 8,855 $ — $ — $ 8,855 Common Stock warrant liability - Private Placement Warrants — 5,082 — 5,082 Total liabilities $ 8,855 $ 5,082 $ — $ 13,937 December 31, 2021 Level 1 Level 2 Level 3 Balance Assets: Money market funds $ 94,973 $ — $ — $ 94,973 Total assets $ 94,973 $ — $ — $ 94,973 Liabilities: Common Stock warrant liability - Public Warrants $ 4,486 $ — $ 4,486 Common Stock warrant liability - Private Placement Warrants $ 2,575 $ 2,575 Total liabilities $ 4,486 $ 2,575 $ — $ 7,061
Schedule of Black-Scholes Option Pricing Model Assumptions	The Company re-measured the preferred stock warrant liability to its estimated fair value as of March 31, 2021, using the Black-Scholes option pricing model with the following assumptions: March 31, 2021 Series A preferred stock value per share $ 18.23 Exercise price of warrants $ 0.76 Term in years 5.5 Risk-free interest rate 1.04 % Volatility 67.00 % Dividend yield 0.00 %
Reconciliation of Preferred Stock Warrant Liability Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Level 3)	The following table presents a reconciliation of the Company’s preferred stock warrant liability measured at fair value on a recurring basis using significant unobservable inputs (Level 3) as of March 31, 2021: Preferred Stock Warrant Liability Balance as of December 31, 2020 $ 2,993 Change in fair value included in other income 4,608 Balance as of March 31, 2021 $ 7,601

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable to Common Stockholders (Tables)	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Summary of Net Loss Attributable to Common Stockholders	The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share amounts): Three Months Ended March 31, 2022 2021 Numerator: Net loss attributable to common stockholders (1) $ (28,758) $ (7,857) Denominator: Weighted-average common shares used in computed net loss per share attributable to common stockholders basic and diluted 110,384,313 22,233,820 Net loss per share attributable to common stockholders basic and diluted $ (0.26) $ (0.35) (1) For the three months ended March 31, 2021, the Company did not allocate its net loss to participating redeemable convertible preferred stock as those shares are not obligated to share in the losses of the Company. As of March 31, 2022, the Company no longer has participating redeemable convertible preferred stock.
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following potentially dilutive outstanding securities were excluded from the computation of diluted net loss per share due to their anti-dilutive effect: As of March 31, 2022 Stock options 9,866,965 RSUs 6,557,326 PRSUs 1,842,105 ESPP shares committed 234,133 Common stock warrants 18,100,000 Total 36,600,529 The Company’s 2,807,500 unvested earnout shares were excluded from the calculation of basic and diluted per share calculations as the vesting conditions have not yet been met as of March 31, 2022. As of March 31, 2021 Stock options 11,186,265 Common stock warrants 942,623 Convertible notes 4,573,466 Preferred stock 61,809,312 Preferred stock warrants 889,765 Total (1) 79,401,431 (1) Securities shown as of March 31, 2021 have been retrospectively adjusted reflecting the exchange ratio of approximately 2.053 established in the Merger. See Part II, Item 8 "Financial Statements and Supplementary Data - Note 3 to the Consolidated Financial Statements - Merger" in the 2021 Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the "Form 10-K") for more information.

Segments (Tables)

Segments (Tables)	3 Months Ended
	Mar. 31, 2022
Segment Reporting [Abstract]
Revenue by Geographic Areas	Revenue by geographic area is based on the delivery address of the customer and is summarized as follows (in thousands): Three Months Ended March 31, 2022 2021 United States $ 18,712 $ 20,534 International 2,826 1,377 Total revenues $ 21,538 $ 21,911
Schedule of Long-Lived Assets by Geographical Area	The Company’s property and equipment, net, by geographic area are summarized as follows as of (in thousands): March 31, 2022 December 31, 2021 United States $ 610 $ 705 International 1,128 1,165 Total property and equipment, net $ 1,738 $ 1,870

Basis of Presentation - Additio

Basis of Presentation - Additional Information (Details) - USD ($) $ in Thousands	Jul. 15, 2021	Mar. 31, 2022	Dec. 31, 2021
Inventory [Line Items]
Inventory		$ 24,713	$ 17,980
Sales returns not yet received		2,047
Accumulated Deficit		172,180	143,422
Net proceeds received	$ 133,889
Returned Inventory Received
Inventory [Line Items]
Inventory		6,172
Customers For Which Returns Are Expected To Be Received
Inventory [Line Items]
Accrued sales returns resulting from FDA Warning Letter		$ 18,210	$ 20,145

Certain Balance Sheet Account_2

Certain Balance Sheet Accounts - Schedule of Property and Equipment (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 3,953	$ 3,776
Less accumulated depreciation and amortization	(2,215)	(1,906)
Property and equipment, net	1,738	1,870
Tooling and manufacturing equipment
Property, Plant and Equipment [Line Items]
Total property and equipment	2,481	2,333
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Total property and equipment	579	579
Computer equipment
Property, Plant and Equipment [Line Items]
Total property and equipment	654	625
Software
Property, Plant and Equipment [Line Items]
Total property and equipment	213	213
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 26	$ 26

Certain Balance Sheet Account_3

Certain Balance Sheet Accounts - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Intangible assets, net	$ 2,098,000		$ 1,696,000
Accumulated amortization	368,000		329,000
Capitalized software development costs	1,541,000		1,101,000
Capitalized computer software, amortization	0
Impairment of intangible assets, finite-lived	0	$ 0
Accrued sales return current	$ 20,668,000		21,179,000
Preferred stock authorized (in shares)	100,000,000
Preferred stock, par or stated value per share (in dollars per share)	$ 0.0001
Preferred stock outstanding (in shares)	0
Customers For Which Returns Are Expected To Be Received
Property, Plant and Equipment [Line Items]
Accrued sales returns resulting from FDA Warning Letter	$ 18,210,000		$ 20,145,000
Tooling and manufacturing equipment
Property, Plant and Equipment [Line Items]
Depreciation and amortization expense	190,000	150,000
Property and Equipment
Property, Plant and Equipment [Line Items]
Depreciation and amortization expense	$ 309,000	$ 214,000

Certain Balance Sheet Account_4

Certain Balance Sheet Accounts - Summary of Changes In Accrued Warranty (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Movement in Standard Product Warranty Accrual [Roll Forward]
Accrued warranty, beginning of period	$ 661	$ 924
Provision for warranties issued during the period	200	242
Settlements of warranty claims during the period	(136)	(244)
Accrued warranty, end of period	$ 725	$ 922

Leases - Narrative (Details)

Leases - Narrative (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2022USD ($)arrangement	Mar. 31, 2021USD ($)	Jan. 01, 2022USD ($)	Dec. 31, 2021USD ($)
Lessee, Lease, Description [Line Items]
Right of use assets, net	$ 2,727		$ 3,003
Lease liabilities	3,439		3,764
Accrued and other expenses	(35,156)			$ (31,730)
Other long-term liabilities	(197)			$ (712)
Operating lease cost	346
Short-term and variable lease cost	$ 11
Number of sublease arrangements | arrangement	4
Sublease income	$ 113	$ 17
Rent expense		$ 371
Cumulative Effect, Period of Adoption, Adjustment
Lessee, Lease, Description [Line Items]
Accrued and other expenses			234
Other long-term liabilities			$ 527
Minimum
Lessee, Lease, Description [Line Items]
Remaining lease term	2 years
Sublease remaining lease term	6 months
Maximum
Lessee, Lease, Description [Line Items]
Remaining lease term	5 years
Sublease remaining lease term	2 years 6 months

Leases - Impact of New Lease St

Leases - Impact of New Lease Standard on Balance Sheet (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Jan. 01, 2022
Leases [Abstract]
Right of use assets, net	$ 2,727	$ 3,003
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued and other expenses
Accrued and other expenses	$ 1,336
Noncurrent lease liabilities	2,103
Total lease liabilities, net	$ 3,439	$ 3,764
Weighted average remaining lease term	2 years 3 months 18 days
Weighted average discount rate	6.50%

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow Information Related to Leases (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2022USD ($)
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows	$ 385

Leases - Schedule of Future Mat

Leases - Schedule of Future Maturities of Lease Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Jan. 01, 2022
Leases [Abstract]
2022 (excluding the three months ended March 31, 2022)	$ 1,156
2023	1,587
2024	953
Total lease payments	3,696
Less: imputed interest	(257)
Total	$ 3,439	$ 3,764

Leases - Schedule of Expected F

Leases - Schedule of Expected Future Sublease Receipts (Details) $ in Thousands	Mar. 31, 2022USD ($)
Leases [Abstract]
2022 (excluding the three months ended March 31, 2022)	$ 947
2023	1,178
2024	679
Total expected sublease receipts	$ 2,804

Leases - Schedule of Future M_2

Leases - Schedule of Future Maturities of Lease Liabilities, Topic 840 (Details) $ in Thousands	Dec. 31, 2021USD ($)
Leases [Abstract]
2022	$ 1,541
2023	1,587
2024	953
Total	$ 4,081

Deferred Revenues (Details)

Deferred Revenues (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Recognition of deferred revenues	$ 550	$ 732
Minimum
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Service period of the performance obligations	5 months
Maximum
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Service period of the performance obligations	27 months

Deferred Revenues- Summary of C

Deferred Revenues- Summary of Changes in the Total Deferred Revenues Balance (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Contract With Customer, Liability [Roll Forward]
Beginning balance	$ 1,235	$ 1,802
Deferral of revenues	744	818
Recognition of deferred revenues	(667)	(895)
Ending balance	$ 1,312	$ 1,725

Long-Term Debt and Other Fina_3

Long-Term Debt and Other Financing Arrangements - Summary of the Company's Long-term Indebtedness (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Line of Credit Facility [Line Items]
Total debt	$ 13,620	$ 16,534
Less: current portion	(7,120)	(8,534)
Less: debt discount and debt issuance costs	(7)	(7)
Long-term debt, net	6,493	7,993
Term Note Payable to SVB
Line of Credit Facility [Line Items]
Total debt	12,500	14,000
Financed Insurance Premium
Line of Credit Facility [Line Items]
Total debt	$ 1,120	$ 2,534

Long-Term Debt and Other Fina_4

Long-Term Debt and Other Financing Arrangements - Narrative (Details) $ in Thousands	Jan. 30, 2022USD ($)	Mar. 31, 2022USD ($)payment	Dec. 31, 2021USD ($)payment	Jan. 31, 2022USD ($)
Debt Instrument [Line Items]
Total debt		$ 13,620	$ 16,534
Term Note Payable to SVB
Debt Instrument [Line Items]
Total debt		$ 12,500	14,000
Debt instrument, number of consecutive monthly payments | payment		30
Financed Insurance Premium
Debt Instrument [Line Items]
Total debt		$ 1,120	2,534
Financed insurance liability to be paid			$ 4,699
Number of monthly payments | payment			10
Financed insurance premium accrued interest rate			0.0359%
Line of Credit
Debt Instrument [Line Items]
Borrowing capacity		17,500
Cash and cash availability streamline threshold		$ 50,000
Actual interest rate		5.50%
Draw against line of credit		$ 4,644
Minimum | Term Note Payable to SVB | Prime Rate
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate	0.035%	2.50%
Minimum | Line of Credit
Debt Instrument [Line Items]
Cash and cash availability EBITDA covenant threshold	$ 5,000
Minimum | Line of Credit | All Other Times
Debt Instrument [Line Items]
Interest rate	1.25%	1.25%
Minimum | Line of Credit | Prime Rate | Streamline Period In Effect
Debt Instrument [Line Items]
Interest rate	0.75%	0.75%
Maximum | Term Note Payable to SVB | Prime Rate
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate	0.065%	5.75%
Maximum | Line of Credit
Debt Instrument [Line Items]
Cash and cash availability EBITDA covenant threshold				$ 30,000
Maximum | Line of Credit | All Other Times
Debt Instrument [Line Items]
Interest rate	6.00%	5.00%
Maximum | Line of Credit | Prime Rate | Streamline Period In Effect
Debt Instrument [Line Items]
Interest rate	5.50%	5.00%

Long-Term Debt and Other Fina_5

Long-Term Debt and Other Financing Arrangements - Summary of Future Aggregate Maturities of Notes Payable (Details) $ in Thousands	Mar. 31, 2022USD ($)
Debt Disclosure [Abstract]
2022 (excluding the three months ended March 31, 2022)	$ 5,620
2023	6,000
2024	2,000
Total	$ 13,620

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details)	1 Months Ended
	Nov. 30, 2021claim
Commitments and Contingencies Disclosure [Abstract]
Number of new claims filed	2

Share-based Compensation - Addi

Share-based Compensation - Additional Information (Details) - USD ($) $ in Thousands	Jan. 01, 2022	Mar. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized stock-based compensation costs related to non-vested options		$ 6,457
Software
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation capitalized		$ 18
PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)		1,842,105
Vesting period		4 years
Unrecognized share-based compensation cost, period for recognition		2 years 3 months 10 days
Unrecognized stock-based compensation costs related to unvested RSUs		$ 4,262
ESPP shares committed
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock plan discount	15.00%
Stock plan offering period	6 months
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period		4 years
Unrecognized share-based compensation cost, period for recognition		2 years 7 months 13 days
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period		4 years
Unrecognized share-based compensation cost, period for recognition		3 years 5 months 8 days
Unrecognized stock-based compensation costs related to unvested RSUs		$ 18,976

Share-based Compensation - Stoc

Share-based Compensation - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation	$ 3,318	$ 828
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation	1,544	398
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation	740	194
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation	$ 1,034	$ 236

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Assets and Liabilities Fair Value Measurement (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets	$ 68,726	$ 94,973
Total liabilities	13,937	7,061
Common Stock warrant liability - Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities	8,855	4,486
Common Stock warrant liability - Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities	5,082	2,575
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets	68,726	94,973
Total liabilities	8,855	4,486
Level 1 | Common Stock warrant liability - Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities	8,855	4,486
Level 1 | Common Stock warrant liability - Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets	0	0
Total liabilities	5,082	2,575
Level 2 | Common Stock warrant liability - Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities	0
Level 2 | Common Stock warrant liability - Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities	5,082	2,575
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets	0	0
Total liabilities	0	0
Level 3 | Common Stock warrant liability - Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities	0	0
Level 3 | Common Stock warrant liability - Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities	0
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets	68,726	94,973
Money market funds | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets	68,726	94,973
Money market funds | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets	0	0
Money market funds | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets	$ 0	$ 0

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Black-Scholes Option Pricing Model Assumptions (Details) - Common Stock warrant liability - Public Warrants	Mar. 31, 2021
Series A preferred stock value per share
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value measurement input	18.23
Exercise price of warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value measurement input	0.76
Term in years
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Expiration period of warrants	5 years 6 months
Risk-free interest rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value measurement input	0.0104
Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value measurement input	0.6700
Dividend yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value measurement input	0

Fair Value Measurements - Recon

Fair Value Measurements - Reconciliation of Preferred Stock Warrant Liability Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Level 3) (Details) - Common Stock warrant liability - Public Warrants $ in Thousands	3 Months Ended
	Mar. 31, 2021USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 2,993
Change in fair value included in other income	4,608
Ending Balance	$ 7,601

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Tax Disclosure [Abstract]
Income tax expense	$ 7	$ 5

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable to Common Stockholders - Summary of Computation of Net Loss Attributable To Common Stockholders (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Numerator:
Net loss attributable to common stockholders	$ (28,758)	$ (7,857)
Denominator:
Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic (in shares)	110,384,313	22,233,820
Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, diluted (in shares)	110,384,313	22,233,820
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.26)	$ (0.35)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.26)	$ (0.35)

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable to Common Stockholders - Antidilutive Securities Excluded from Computation of EPS (Details)	3 Months Ended
	Mar. 31, 2022shares	Mar. 31, 2021shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share	36,600,529
Shares subject to vesting (in shares)	2,807,500
Redeemable Convertible Preferred Stock | Common Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Convertible preferred stock, conversion ratio	2.053	2.053
Old Owlet
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share		79,401,431
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share	9,866,965
Stock options | Old Owlet
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share		11,186,265
RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share	6,557,326
PRSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share	1,842,105
ESPP shares committed
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share	234,133
Common stock warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share	18,100,000
Common stock warrants | Old Owlet
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share		942,623
Convertible notes | Old Owlet
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share		4,573,466
Preferred stock | Old Owlet
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share		61,809,312
Preferred stock warrants | Old Owlet
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share		889,765

Segments - Additional Informati

Segments - Additional Information (Details)	3 Months Ended
	Mar. 31, 2022segment
Segment Reporting [Abstract]
Number of operating segments	1

Segments - Revenue by Geographi

Segments - Revenue by Geographic Areas (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ 21,538	$ 21,911
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	18,712	20,534
International
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ 2,826	$ 1,377

Segments - Schedule of Long-Liv

Segments - Schedule of Long-Lived Assets by Geographical Area (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Revenues from External Customers and Long-Lived Assets [Line Items]
Total property and equipment, net	$ 1,738	$ 1,870
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Total property and equipment, net	610	705
International
Revenues from External Customers and Long-Lived Assets [Line Items]
Total property and equipment, net	$ 1,128	$ 1,165